19 June 2013
Keywords: alnylam, isis, form, regulus, thera, jv, rnai
Article | 17 September 2007
RNAi therapeutics specialist Alnylam Pharmaceuticals and fellow USA-based firm Isis Pharmaceuticals have announced the launch of a new
joint venture, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 September 2007
8 October 2007
20 August 2007
© 2013 thepharmaletter.com